The more partnerships domestic pharmaceutical companies make with multinational companies, the stricter CP policies gets

Is it really inevitable for top domestic pharmaceutical companies promoting introduced products of multinational pharmaceutical companies to have tight CP (Compliance Program) policies?

It is criticized in the pharmaceutical industry that CP policies of domestic pharmaceutical companies get stricter as more products of multinational pharmaceutical companies are introduced.

In particular, dome...